MiBUP: A pilot randomized controlled trial of low-dose initiation of buprenorphine for opioid use disorder: Design and rationale
As a pilot clinical trial this study will inform design of a fully powered RCT to test buprenorphine LDI in the ambulatory setting.<i>Trial registration</i>ClinicalTrials.gov, NCT05450718: date of registration: June 22, 2022; https://clinicaltrials.gov/study/NCT05450718?term=NCT05450718&rank=1.
Authors
- Allan J. Fox (ORCID: https://orcid.org/0000-0001-5465-5801)
- Tiffany Lu (ORCID: https://orcid.org/0000-0002-9750-2490)
- Haruka Minami (ORCID: https://orcid.org/0000-0002-0169-0459)
- Benjamin T. Hayes (ORCID: https://orcid.org/0000-0002-4282-6869)
- Laila Khalid
- Annika Sabado (ORCID: https://orcid.org/0009-0004-8682-5472)
- Matthew Holm
- Kristine Torres-Lockhart
- Chenshu Zhang
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Fordham University (US)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1016/j.conctc.2026.101594
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00